After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Merrimack Pharmaceuticals' (MACK) stock rating was reduced to 'neutral' at JPMorgan earlier today.
The first day of trading in the fourth quarter was rough as stocks declined Monday.
U.S. stocks closed lower on Monday amid lower construction spending, mostly strong auto sales, and better-than-expected manufacturing data. Crude oil increased and utilities lagged.
U.S. stocks pare losses in afternoon trading Monday as investors grapple with mixed data, but oil prices increase.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.